Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Other financing activities (2020 - 2026)

Equillium (EQ) posted quarterly Other financing activities of $448000.0 for Q1 2026, up 1078.95% year-over-year from $38000.0 in Q1 2025, and up 101.71% quarter-over-quarter from -$26.3 million in Q4 2025.

Analysis

Equillium (EQ) Other financing activities (2020 - 2026) Analysis & Trends

Equillium (EQ) has reported Other financing activities for 7 consecutive years, with $448000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Other financing activities rose 1078.95% year-over-year to $448000.0; the TTM figure through Mar 2026 stood at $2.2 million (up 7386.67% YoY), while the FY2025 annual figure was $1.8 million, up 45800.0% from the prior year.
  • Other financing activities improved to $448000.0 in Q1 2026 per EQ's latest filing, from -$26.3 million in the prior quarter.
  • Across five years, Other financing activities topped out at $28.1 million in Q3 2025 and bottomed at -$26.3 million in Q4 2025.
  • Historically, Other financing activities has averaged $335571.4 across 5 years, with a median of $73000.0 in 2022.
  • Annual changes were most pronounced in 2025 — Other financing activities plunged 30080.46% — and 2026, when it surged 1078.95%.
  • Equillium's Other financing activities stood at $73000.0 in 2022, then increased by 8.22% to $79000.0 in 2023, then tumbled by 210.13% to -$87000.0 in 2024, then slumped by 30080.46% to -$26.3 million in 2025, then jumped by 101.71% to $448000.0 in 2026.
  • Business Quant data shows EQ's Other financing activities at $448000.0 in Q1 2026, -$26.3 million in Q4 2025, and $28.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Equillium 249.33 Mn 249.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -100,000.00
Mar 31, 2026 34.90 Mn
Dec 31, 2025 -184,000.00
Sep 30, 2025 28.06 Mn
Jun 30, 2025 -15,000.00
Mar 31, 2025 53,000.00
Dec 31, 2024 -87,000.00
Dec 31, 2023 79,000.00
Dec 31, 2022 73,000.00
Dec 31, 2021 -29.01 Mn
Jun 30, 2021 -51,000.00
Mar 31, 2021 29.96 Mn
Dec 31, 2020 60,000.00